Search
for
Sort by
Research 31–60 of 1000+
- Application of Thulium 1927-nm Laser for Androgenic Alopecia Treatment in Indonesian Patients.
- Application of Thulium 1927-nm Laser for Androgenic Alopecia Treatment in Indonesian Patients
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study
- P153 : Safety and Efficacy of botulinum toxin on male pattern baldness
- 62471 Topical Finasteride Combined with Minoxidil for Androgenetic Alopecia: An Updated Systematic Review and Meta-analysis
- Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo‐controlled study
- Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
- Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single‐Arm, Multi‐Center, phase III equivalent clinical study
- The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
- Improving the efficacy of anti-hair loss drugs treatments with a cosmetic lotion containing caffeine, taurine and growth factors
- Efficacy of Dr. SKS Hair Booster Serum in the Treatment of Female Pattern Alopecia in Patients With PCOS: An Open-Label, Non-randomized, Prospective Study
- A Segmental Approach to Scoring Hair Density from Global Images: Introducing the Scalp Coverage Scoring Method for Clinical Trials and Practice
- Evaluation of Effectiveness of i-PRF Mesotherapy and i-PRF Mesotherapy with Microneedling in Treatment of Male Androgenetic Alopecia: A Comparative Study
- <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
- Topical Cetirizine in Androgenetic Alopecia: A Preliminary Study
- Highlights
- Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
- Clinical Characteristics and Treatment of Acne with Sensitive Skin
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Utilizing Electromagnetic Radiation for Hair Growth
- Scoring systems for pemphigus
- Efficacy of 5% Minoxidil versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair Loss
- Impact of Clinical Response on Different Approved Doses in Japan and the United States
- Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Assessment of hair loss: clinical relevance of hair growth evaluation methods
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Reliability and Validity of a Photographic Method for Measuring Facial Hair Density in Men
- Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss
- The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta‐analysis